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The  glomerulus  represents  a highly  structured  ﬁltration  unit,  composed  of glomerular  endothelial  cells,
mesangial  cells,  podocytes  and  parietal  epithelial  cells.  During  glomerulogenesis  an  intricate  network






required  to guarantee  accurate  evolvement  of a functional,  complex  3-dimensional  glomerular  archi-
tecture.  Here,  we  want  to  provide  an overview  on the critical  steps  and  relevant  signaling  cascades  of
glomerular  development.
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. Nephrogenesis & nephron induction – road map  for
lomerular development
The glomerulus as the most proximal part of the nephron is
he essential functional unit for renal ﬁltration. The ﬁlter itself is
omposed of a multi-layered and -cellular barrier, including the
enestrated endothelium of glomerular capillaries, the glomerular
asement membrane and the slit-diaphragm, connecting adja-
ent podocyte foot processes [1–3]. Malfunction in any of these
omponents results in the loss of size- and charge-selective ﬁl-
ration, clinically characterized by proteinuria [4]. The complex
ellular architecture of the glomerulus is based on a tightly orches-
rated developmental program involving the interplay of numerous
ranscription factors, paracrine secretory pathways and epigenetic
ontrol mechanisms.
Ontogenetically three stages of kidney differentiation can be
istinguished beginning with the pronephros, followed by the
esonephros and ﬁnally resulting in the metanephric kidney (for
xcellent review see [5]). During mammalian kidney development
he pronephros and mesonephros represent only transient struc-
ures, while the metanephric kidney persists. The developmental
rogram of the metanephric kidney is characterized by reciprocal
nterplay between the ureteric bud and the metanephric mes-
nchyme [6], resulting in the formation of the renal vesicle (Fig. 1).
his ﬁrst initiation step of glomerular development occurs around
11.5 in murine organogenesis and around the 5th week of gesta-
ion in humans [7]. Both, the ureteric bud (UB) and the metanephric
esenchyme (MM)  originate from the intermediate mesoderm:
hile the UB forms from the caudal portion of the nephric duct, the
etanephric mesenchyme condensates in close proximity to the
B. Previous studies using different experimental approaches have
eciphered the underlying signaling pathways in the reciprocal
nterplay between MM and the UB. While UB tips lead to con-
ensation and organization of the loosely arranged MM,  branching
f the UB is elicited in turn (for excellent review [5,8]). The MM
ontributes to the development of all proximal components of the
ephron, while collecting ducts, renal calyces and the remaining
rinary tract collection system will emanate from the UB [8].
With the condensation of the MM the renal vesicle is formed
epresenting the earliest epithelial structure of the future nephron.
herefore, the inductive signals of the UB do not only lead to a
orphological change in the MM,  but also activate a mesenchymal
o epithelial transition. Furthermore, a decisive fate speciﬁcation
ccurs around this developmental stage, characterized by a division
nto either Foxd1 or mainly Six2 positive progenitors. While Foxd1
ositive populations will give rise to several different cell types
uch as mesangial cells or angioblasts, all epithelial cell types of the
ephron originate from the Six2 positive progenitor population [9].
The condensation of the MM and formation toward the renal
esicle structure marks the initiation of nephron development
haracterized by a mesenchymal to epithelial transition. The
equence of developmental steps has mainly been classiﬁed by
nderlying morphological characteristics. After initial condensa-
ion of the renal vesicle, the comma-shaped bodies are formed
Fig. 1). With the formation of a cleft in the more distal part of the
omma-shaped bodies, the next morphological level, the S-shaped
ody, is determined. Cells directly adjacent to the cleft are speciﬁed
oward the podocyte population, whereas cells in the more caudal
egion of the S-shaped body will give rise to the proximal tubule
ompartment. At this stage of glomerular development paracrine
ignaling is of particular importance: VEGF secreted by prema-
ure podocytes attracts endothelial cell progenitors to migrate into
he S-shaped body cleft [10,11]. The intruding endothelial cells
robably derive from angioblasts, which originated from the non-
ephron progenitor cells of the metanephric mesenchyme [12]. The
xact origin of mesangial cells (metanephric mesenchyme versuspmental Biology 36 (2014) 39–49
multipotent hematopoetic progenitor lineage), which also intrude
at this stage into the cleft, is still unresolved [13,14]. Ongoing
maturation then ﬁnally leads to the fully developed glomerulus,
consisting of 4 highly speciﬁed cell populations represented by
the fenestrated endothelium, mesangial cells, podocytes and the
parietal epithelial cells of the Bowman’s capsule.
2. Gaining foothold – decisive steps in podocyte
development
2.1. Formation of the slit diaphragm
The ﬁrst podocyte precursor cells might be speciﬁed around
the comma-shaped body stage. During further development of
the glomerulus podocytes undergo a dramatic change in cellu-
lar morphology and concomitantly loose typical characteristics
of classical epithelial cells. At the very early stage of glomerular
maturation, podocytes represent a classical columnar epithelium
(comma-shaped body), but with the intrusion of endothelial cells
and unfolding of capillary loops these cells start to dramatically
expand their apical surface seemingly resulting in a translocation
of their apical cell-junctional belt toward the basal side. This apical
membrane expansion not only leads to a change in cellular archi-
tecture, but is at the same time accompanied by a sequential change
of cell-junctional protein expression (Fig. 2).
While cadherins and tight junction proteins like ZO-1 predom-
inate in the apical junctional belt [15,16] super IgG family proteins
like Nephrin and NEPH1 are started to be expressed at basal
cell–cell contact sites after apical podocyte membrane expansions
[17–19]. Thus, tight junctions are restructured and replaced by a
unique, modiﬁed adherens-junction like contact, termed the slit
diaphragm [18]. This morphogenetic switch is paralleled with the
increased expression of specialized apical surface proteins such as
the sialoglycoprotein Podocalyxin which contributes to the highly
negative charge on the podocyte cell surface [20]. Interestingly, a
reappearance of tight junctions and apical transition of junctional
components can be observed in glomerular diseases [20,21].
The morphogenetic transformation of podocytes from a colum-
nar epithelium toward a highly arborized cellular morphology with
interdigitating foot processes suggests an utmost importance for
underlying polarity programs. In general, epithelial apicobasal cell
polarity is organized by the asymmetric localization of three main
polarity complexes: (a) The apical Crumbs complex (Crumbs, PALS1
and PATJ), (b) the apical PAR complex and (c) the basolateral Scrib-
ble complex (Scribble, DLG and LGL [22,23]). A series of recent
studies could demonstrate the fundamental role of the Par/aPKC
polarity complex for podocyte development, as various mouse
models deﬁcient for aPkc in the podocyte result in loss of podocyte
foot processes and congenital nephrotic syndrome [24–27]. Fur-
thermore, a genetic screen in zebraﬁsh also identiﬁed Crumbs
(crb2b) to be required for podocyte foot process development [28].
In contrast, conditional knockout of the basolateral polarity protein
Scribble was not associated with any obvious podocyte defects [29].
2.2. Morphogenetic programs controlling the development of
podocyte foot processes
One main feature of podocytes, aside from the unique slit
diaphragm junction, is their peculiar morphology with primary and
secondary processes, which was naturally eponymous for this cell
type (from Greek “о’ pous”, genitive “оó podos”). Together
with the slit diaphragm, podocyte foot processes (FPs) are inti-
mately involved in the integrity of the glomerular ﬁltration barrier
and any form of podocyte malfunction results in a uniform patho-
logical response which is termed podocyte foot process effacement
C. Schell et al. / Seminars in Cell & Developmental Biology 36 (2014) 39–49 41
Fig. 1. Nephron development. (A) In mammals, the kidney develops from the metanephric mesenchyme upon invasion of the ureteric bud out of the nephric duct. (B and
C . (D) T



































w)  The ureteric bud starts branching within the growing metanephric mesenchyme
ap  mesenchyme. (E) Renal vesicles form from the condensed cap mesenchyme. (F
ngioblasts in the s-shaped body. (H) The developing nephron connects with the co
30]. This pathological hallmark is characterized by retraction of
Ps, restructuring of the FP actin cytoskeleton and loss of slit
iaphragm junctions [31–33]. Based on morphological criteria and
he molecular composition, podocyte FPs are often compared to
endritic spines of neurons [34]. Albeit sharing similar molecular
achineries and expression patterns for certain genes of neurons
e.g. Nestin,  Synaptopodin,  Dendrin [35–38]) podocytes substantially
iffer in terms of morphological dynamics and most importantly
re non-excitable cells.
But how are these processes ﬁnally formed and assembled, gen-
rating this complex interdigitating network? In general at least
wo different hypotheses exist on this question [39]: the ﬁrst
ypothesis describes podocyte FP formation as an active mech-
nism, where two spatially separated cells generate protrusions
oward each other. This theory is mainly based on observations
n keratinocytes forming ﬁlopodia-like processes to generate a
ell–cell contact mediated via cadherins [40]. In contrast, the sec-
nd model favors a rather passive mode for assembly of podocyte
Ps. Based on the process of junctional belt translocation and
rogressing polarization, the basal compartment of podocytes is
urther speciﬁed, eventually resulting in the interdigitating net-
ork of FPs. Despite great advances in life imaging techniques
41,42] the question whether foot process assembly is rather an
ctive or passive event is so far not completely solved (while neu-
onal dendrites deﬁnitely rely on active patterning mechanisms
43]). However, analysis of transgenic mouse models allowed for
t least some retrospective conclusions regarding certain biolog-
cal programs in podocyte FP development. For example, it could
e demonstrated that the loss of the sialoglycoprotein Podocalyxin
esults in podocytes without any discernible foot processes [20].
odocalyxin was shown to physically interact with the ERM com-
lex (Ezrin, Radixin and Moesin) and therefore modulates the actin
ytoskeleton, indicating that regulation of the actin cytoskeleton
ight be essentially involved in FP formation [44]. This notion
as further substantiated by the observation of a direct linkhe mesenchyme condenses around the ureteric bud tips forming the Six2-positive
ft develops in the comma-shaped bodies. (G) Podocyte progenitors start to attract
g duct.
between the slit diaphragm molecule Nephrin, the podocyte actin
cytoskeleton and the actin branching machinery via the adaptor
molecules NCK1/2 (including N-WASP and the ARP2/3 complex –
[45]). Mice with deletion for Nck1/2 in podocytes were born with
heavily retracted foot processes and displayed features of congen-
ital nephrotic syndrome. Altogether, these observations suggested
an essential role for the process of actin polymerization and branch-
ing in FP development. In fact, this molecular mechanism is also
required for the generation and active protrusion of the lamel-
lipodium in cultured cells [46]. A more recent study illustrated that
despite altered actin branching, foot processes could be formed,
suggesting that actin branching is rather important for the stabi-
lization of FPs [47]. Furthermore, these ﬁndings are supported by a
series of recent studies focusing mainly on the role of small GTPases
for podocyte function: here, only the deletion of Cdc42 resulted
in a similar phenotype as described for Nck1/2, whereas the other
major GTPases RhoA and Rac1 had no inﬂuence on foot process for-
mation [48,49]. Interestingly, Cdc42 forms a functional complex
with the Par6/Par3/atypical protein kinase C (aPKC)-containing
Par polarity complex. Like Cdc42,  the podocyte-speciﬁc loss of
both aPKC (lambda and iota) isoforms results in the inability to
establish a podocyte process network underlining the role of the
Cdc42/Par6/Par3/aPKC complex as a key regulator of podocyte pro-
cess formation [25–27]. In general, each of these aforementioned
GTPases orchestrates a functional repertoire of downstream events,
which were most extensively characterized in cultured cells [50]:
RhoA drives the activation of the myosin network and is involved
in the formation of stress ﬁbers, Rac1 facilitates protrusive activ-
ity in the lamellipodium, whereas Cdc42 is involved in cell polarity
determination and the generation of ﬁlopodia. In summary, these
studies indicate a critical role for a ﬁne-tuned actin cytoskele-
ton for podocyte FP formation. Furthermore, with regard to the
observed phenotype of Cdc42 podocyte-speciﬁc knockout mice and
the known cellular functions of this GTPase, the formation of ﬁlopo-
dia might reﬂect at least to some extent podocyte FP assembly in
42 C. Schell et al. / Seminars in Cell & Develo
Fig. 2. Speciﬁcation of podocyte cell–cell contacts. (A) In the renal vesicle and
comma-shaped stage, the podocyte progenitors display a typical epithelial mor-
phology with apical cell–cell contacts. (B) During s-shaped stage, apical membranes





















dhe  capillary loop stage of immature glomeruli, the podocyte cell–cell contacts are
ocated at the basal side. (D) At mature glomeruli, the podocyte foot processes form
 specialized cell–cell contact, the slit diaphragm.
ivo. Nevertheless, the question whether FP formation is an active
r passive process still awaits ﬁnal elucidation.
. United we stand – contribution of endothelial, mesangial
nd parietal cells to the glomerular unit
.1. Development of the glomerular vasculature
In the S-shaped stage of glomerular development, glomerular
asculogenesis starts by inﬁltration of angioblasts into the cleft
f the S-shaped glomerular body [51]. The major driving force
or the development of the glomerular vasculature is vascular
ndothelial growth factor A (VEGF-A) which is expressed in sev-
ral pro-angiogenic isoforms by developing podocytes [52]. VEGF-A
inds to its receptors VEGFR1 (Flt-1), VEGFR-2 (Flk-1) and the
o-receptors neuropilin-1 on the inﬁltrating endothelial cell pre-
ursors, which start to proliferate and differentiate in the vascular
left [53]. Podocyte-speciﬁc homozygous deletion of Vegf-A dra-
atically reduced the number of endothelial cells within glomeruli
nd resulted in a failure to develop a functional ﬁltration bar-
ier [54]. In contrast, heterozygous Vegf-A deletion in podocytes
id not disturb glomerular development. However, these micepmental Biology 36 (2014) 39–49
developed renal disease resembling preeclampsia and end-stage
renal failure by 9 weeks of age, indicating an important role for
VEGF-A in the maintenance of the glomerular ﬁltration barrier
[54]. Inhibiting the function of VEGF-A with a blocking antibody or
soluble VEGF receptor sFlt-1 led to podocyte and endothelial cell
damage and proteinuria already 3 h after injection [55]. The dosage
sensitivity of VEGF-A is also demonstrated by overexpression of
VEGF-A164 which caused collapsing glomerulopathy in newborn
mice and reversible disruption of glomerular ﬁltration in adult
mice [54,56]. Vegf-A expression in podocytes is in part dependent
on the transcription factor LMX1B, leading to reduced VEGF pro-
duction and decreased fenestration of endothelial cells in LMX1B
deﬁcient mice [57]. In contrast, the deletion of TGF-ˇ–activated
kinase 1 (TAK1) in podocytes increases VEGF production causing
abnormalities in glomerular and capillary formation [58]. Thus, the
function of tightly balanced VEGF-A expression is indispensable
for the development and maintenance of glomerular structure and
function.
Another factor secreted by the podocyte progenitor cells is
Angiopoietin-1 which binds to its receptor TIE-2 on endothelial
precursor cells. This signal is important for endothelial cell sur-
vival and blood vessel maturation [59,60]. Additionally, temporal
expression of the guidance molecule Ephrin-B2 on podocyte pro-
genitor cells with the correspondent EPHB receptors on vascular
progenitors may regulate localization of the endothelial precursors
[61]. The receptor NOTCH2 is expressed in the epithelial cells of
the developing nephron, while its ligands Jagged1 and DLL4 are
expressed, among others, in the endothelial cells during devel-
opment. In mice, homozygous Notch2 deletion resulted in lack
of vascularization, invasion of mesangial cells and defects of the
epithelial structures [62]. A function for NOTCH signaling was
also described for Drosophila Malpighian tubule development and
Xenopus pronephros ([63–65], see also below).
Having successfully invaded the developing nephron, the
angioblasts start to form a lumen via TGF-1-mediated cell apo-
ptosis [12,66]. During glomerular maturation, the endothelial cells
start to differentiate and ﬂatten, lining the capillary loops. A unique
feature of the glomerular endothelial cells is the 70–100 nm pores
lacking a diaphragm. These fenestrae are localized adjacent to the
GBM and cover 30–50% of the endothelial wall surface. It has been
shown that secretion of VEGF-A by the podocytes leads to fenestrae
formation and maintenance, however, so far the exact mechanism
is not clear [54,55,67–69].
3.2. Glomerular basement membrane
Initially, both podocyte precursors and vascular progenitors are
covered with a normal basement membrane, forming a double-
layer. Both layers then fuse to a single basement membrane, the
glomerular basement membrane (GBM) [53]. Like other basement
membranes, the GBM consists of Laminin, Collagen IV, Nidogen and
Heparin sulfate proteoglycans, mostly Agrin and Perlecan [70,71].
Studies have shown that the turnover of GBM components takes
place at a very slow rate [72]. In the immature glomerulus, the
Laminin trimers contain 1-, 1- and 1-chains (Laminin-111) or
5-, 1-, 1-chains (Laminin-511) [73]. These isoforms are secreted
by both podocytes and endothelial cells. However, during glomeru-
lar maturation, the laminin isoform switches to Laminin-521, also
secreted from both adjacent cell types [73]. Interestingly, avascu-
lar glomeruli in metanephric organ cultures do not contain the
Laminin 2 isoform indicating that this isoform is secreted by the
endothelial cells [74].Another switch from the immature to mature glomerulus occurs
in the Collagen IV isoforms. Like in most basement membranes,
Collagen IV 121 is predominant in the immature GBM. It is
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f the glomerulus causes a switch to Collagen IV 345 [76]. How-
ver, this isoform is produced solely by podocytes [77]. Mutations
n the ˛3(IV), ˛4(IV), or ˛5(IV) genes cause Alport syndrome which
s characterized by hematuria, glomerulonephritis, sensoneurinal
nd ocular abnormalities [78,79]. The switch between Laminin and
ollagen IV isoforms does not occur simultaneously and therefore
eems to be controlled by different mechanisms [80]. The reason for
he developmental switch in Laminin and Collagen isoforms is not
et clear. It has been speculated that the composition of the mature
BM might make it more resilient or aid podocyte differentiation
s well as foot process formation [81].
.3. Mesangial cells
In the metanephric mesenchyme, Osr1-positive cells give rise to
wo distinct cell populations, the Six2-positive cells forming the
ap mesenchyme and the Foxd1-positive cells forming the stro-
al  mesenchyme [82]. From the Foxd1-positive cell population,
any supporting cells of the kidney, such as interstitial ﬁbroblasts,
ericytes and vascular smooth muscle cells (VSMCs) are derived.
esangial cells, which are -SMA-positive, appear to be specialized
SMCs. This population arises when the ﬂk1-positive endothelial
recursor cells start to secrete the growth factor PDGF-B, which
inds to the PDGF receptor (PDGFR) on mesangial cells [83,84].
esangial cells correspondingly invade the forming glomerulus
nd attach to the forming blood vessels. Mice lacking either PDGF-
 or the PDGFR fail to develop mesangial cells [85,86]. PDGFR,
n turn, seems to be controlled by the T-box family transcription
actor Tbx18, as kidneys lacking this transcription factor develop
ewer mesangial cells and display dilated capillary loops [87,88].
t is still unclear whether mesangial cells develop from VSMCs or
he stromal mesenchyme cells in situ or whether a mesangial pro-
enitor population is speciﬁcally attracted by the PDGF-B signal
89]. Within the glomerulus, mesangial cells attach to the vascul-
ture and seem to pull at the endothelial cells, thereby forming
nvaginations which lead to the segmentation of the capillary loops.
he supporting role of mesangial cells for the glomerulus becomes
lear when they are absent, as caused by the lack of PDGF-B or
ts receptor, or their adherence is impaired because of defects in
he basement membrane composition. In these cases, the glomeru-
ar vasculature only forms a single large vessel with a 100-fold
ecreased surface area [83,90] (Fig. 3).
.4. Parietal epithelial cells
A fourth-glomerular cell type is represented by the parietal
pithelial cells (PECs). Adjacent and adjoining to the podocytes, the
isceral epithelial cell layer, they line Bowman’s capsule in a very
hin 0.1–0.3 	m thick single cell layer with 3.5 	m thickness at the
uclei [91]. Their developmental origin is the same as for podocytes.
n the s-shape stage of glomerular development, both lineages sep-
rate and start to express cell-speciﬁc markers. PECs upregulate
xpression of CK8, PAX2, CRIM1, FGF2, PGP9.5, SSeCKS, Claudin-1
nd -2 [92–97] and downregulate Wilm’s tumor suppressor protein
 (WT1), while podocytes express Podocalyxin, WT1, Nephrin and
odocin [98]. At the intersection of PECs and podocytes, transitional
ells can be found in many glomeruli, so-called parietal podocytes.
hese cells express PEC markers as well as many podocyte speciﬁc
arkers and form foot processes onto Bowman’s basement mem-
rane (BBM) [98,99]. This phenotype has also been described in
uman glomeruli, dividing the parietal epithelial cell layer in sev-
ral subsets from vascular to urinary pole [100,101]. The transient
nd overlapping marker proﬁle implicates these cells as possible
odocyte and tubular progenitor cells; however, this has yet to be
roven. A podocyte-PEC transition can also be seen in disease whenpmental Biology 36 (2014) 39–49 43
podocytes dedifferentiate and take up a more immature phenotype
[102].
Important insights into the development of PECs are given by
the knockout of ˇ-catenin in the late s-shape stage of nephrogene-
sis. In Pax8.Cre ˇ-catenin-deﬁcient mice no PECs were visible [103].
Instead, podocytes could be found covering Bowman’s capsule and
forming foot processes onto the BBM. Distorted VEGF secretion
from these podocytes led to ectopic formation of parietal capillaries
around Bowman’s capsule. The glomeruli were hypoplastic, per-
haps due to insufﬁcient recruitment of podocytes, depletion of the
progenitor cell pool or switch in cell fate decision [103]. Currently,
the role of PECs for podocyte regeneration, crescent formation
and scar formation in focal segmental glomerulosclerosis is under
intense investigation [100,104–108].
4. Regulatory networks of glomerular development – Is
transcriptional control all that matters?
4.1. WT-1 – Wilms tumor suppressor protein 1
WT1  was  initially identiﬁed in the search for genetic causes
of the Wilms  tumor (ﬁrst described at the end of the 19th cen-
tury by Max  Wilms) and is probably the most extensively studied
transcription factor in the ﬁeld of kidney and podocyte research.
Wilms  tumor (also known as nephroblastoma) occurs as an aggres-
sively growing tumor of the kidney parenchyma and arises from the
metanephric blastema representing the most common renal cancer
form in children [109]. WT1  belongs to the class of zinc-ﬁnger tran-
scription factors and four different WT1  isoforms are transcribed by
alternative splicing.
Early loss of function studies in mice indicated the impor-
tance of WT1  for genitourinary development, as mice with a
disrupted Wt1  gene displayed complete gonadal and renal agen-
esis [110]. The importance and versatile involvement of WT1  in
genitourinary development was  furthermore underlined by the
identiﬁcation of genetic diseases, the WAGR, Denys–Drash and
Frasiers syndromes [111]. WAGR syndrome (clinically deﬁned by
the occurrence of Wilms  tumor, aniridia, genitourinary abnormal-
ities and mental retardation) is caused by interstitial deletions
at the 11p13 locus covering the Wt1  and Pax6 gene [112–114].
While deletions affecting the Pax6 gene are related to the aniridia
phenotype [115], mutations within the Wt1  gene contribute to
the genitourinary abnormalities and development of the Wilms
tumor [116]. Denys–Drash Syndrome (DDS) shows the occurrence
of diffuse mesangial sclerosis as a main pathological feature and is
often accompanied by nephrotic syndrome. Additionally, patients
present with gonadal dysgenesis and Wilms tumors [117,118]. The
so far identiﬁed spectrum of mutations in DDS displays a broad
heterogeneity, while the most common form is a heterozygous
point mutation within exon 9 affecting the third zinc ﬁnger motif
[111]. Also deletions of zinc ﬁnger 3 and 4 domains are related to
the development of DDS [119,120]. In contrast, Frasier Syndrome
(FS) is characterized by a heterozygous point mutation within a
splice donor site located in intron 9 [121]. This leads to a loss of an
amino acid sequence (lysine-threonine-serin – termed as WT1  -KTS
sequence) between the third and fourth zinc ﬁnger, ﬁnally disrup-
ting the balance of differentially expressed Wt1  isoforms [121,122].
Mutant mouse models with a reduction in +KTS levels resemble the
Frasier syndrome phenotype and therefore highlight the impor-
tance of WT1  isoform ratios for speciﬁc developmental programs
[123]. Patients with FS present with features of focal segmental
glomerulosclerosis, male pseudoheraphroditism and show also a
high risk for the development of gonadoblastomas [124].
WT1  acts as a context-speciﬁc transcription factor and binds
in a sequence-dependent manner to DNA as well as mRNA










































iig. 3. Development of the glomerular endothelial and mesangial cells. (A) At the s
ndothelial cells (EC), which in turn produce PDGF-B attracting mesangial progen
esangial cells attach to the endothelial cells and cause looping of the capillaries. (
he  cleft. (F) The capillary forms as a single dilated loop.
predominantly +KTS form). Despite extensive efforts to identify
nd describe the WT1  controlled transcriptional network, there are
o far only few validated gene targets. This is even more compli-
ated as WT1  appears to act as either a repressor or activator: for
xample WT1  appears to be involved in the regulation of epithe-
ial to mesenchymal transition (EMT) in the developing heart via
ctivation of Snail and repression of Cdh [125]. In contrast, mes-
nchymal to epithelial transition (MET) is regulated by WT1  in
he developing kidney via induction of the Wnt4 gene [126]. In
he context of podocytes, WT1  might be involved in the regulation
f essential key genes like Nphs1 and Podocalyxin [127,128]. More
ecently, several other possible gene targets of WT1  were detected
y employing a novel DDS mouse model and transcriptional pro-
ling of respective mutant mice [129]. Here, three genes were
dentiﬁed, namely Sulf1 (Sulfatase 1), Scel (Sciellin) and Cyp26A1
Cytochrome P450 26A1). While the ﬁrst two were both signiﬁ-
antly downregulated, the latter showed an increased expression.
nly very recently it was demonstrated that WT1  modulates the
xpression of the 6-O-endosulfatases Sulf1 and Sulf2 via VEGF-A
nd FGF2 signaling. Furthermore, mice deﬁcient for SULF1 and
ULF2 developed a kidney phenotype resembling heterozygous
T1  mouse models or patients with WT1  mutations [130].
Based on genetic syndromes and insights from various mouse
odels, it is clear that WT1  is essential for podocyte development.
ut given the high expression levels in matured podocytes, WT1
ight be also involved in the maintenance of these cells. This is
upported by observations in cases of diffuse mesangial sclero-
is, a pathological entity characterized by hyperproliferation of
esangial cells and increased deposition of extracellular matrix
omponents within the glomerular tuft. Although this pathology is
ather incompletely deﬁned, a drastic reduction in WT1  expression
s observed, while concomitantly increased expression of PAX2 is
etected [131]. This suggests that WT1  and probably the down-
tream regulated transcriptional network in podocytes, is also
equired to maintain the intercellular communication of podocytes
nd mesangial cells. This aspect of WT1  controlled paracrine or
ntercellular signaling, is furthermore highlighted by reports on
he regulation of VEGF-A via WT1  [132,133]. More recent studies
dentiﬁed the essential role of WT1  in RNA splicing of VEGF isoformsd stage, podocyte progenitor cells start to produce VEGF-A attracting the invading
lls (MC). (B) The endothelial cells form capillary lumen via cell apoptosis. (C) The
ture glomerulus. (E) In PDGF-B or PDGFR deﬁcient mice, no mesangial cells invade
[134,135]. For example, it was demonstrated that WT1  mutant
cells failed to repress the splicing-factor kinase SRPK1 resulting in
altered splicing of VEGF isoforms, turning cells overall in a pro-
angiogenic state [134].
Although the WT1  controlled transcriptional network is not fully
elucidated, there is no doubt that WT1  is required for podocyte
function and speciﬁcation. Interestingly, a very recent study could
demonstrate that also WT1  itself underlies certain regulatory pro-
grams: miR-193a was  identiﬁed as a potent repressor of WT1  in
podocytes. Upregulation of miR-193a led to downregulation of Wt1
and ﬁnally focal segmental glomerulosclerosis [136].
4.2. LMX1b
LMX1b belongs to the LIM homeodomain proteins and is
expressed in podocytes from the s-stage phase on [137,138]. More-
over, LMX1b is associated with the Nail-Patella-Syndrome (NPS).
Clinically NPS is characterized by a tetrad of manifestations, includ-
ing malformed ﬁnger- and toenails, absent or hypoplastic patellae
and dysmorphic elbows, as well as the occurrence of iliac horns
[139]. Although not included in the characteristic tetrad, NPS
patients also show renal manifestations [140]. The Lmx1b knockout
mouse model was highly reminiscent of the clinical presentation
in human patients [137].
As with WT1, the deﬁnite transcriptional network of LMX1b is
still not fully resolved, but recent progress in conditional mouse
models gave more insights into the role of Lmx1b in the mainte-
nance of podocytes. Using a doxycycline-inducible knockout mouse
model for Lmx1b,  it was  demonstrated that certain actin associ-
ated genes such as Abra and Arl4 might be transcriptional target
genes of Lmx1b [141]. This study highlighted on the one hand the
regulatory role of LMX1B for the podocyte actin cytoskeleton and
furthermore indicated in analogy to WT1  not only a developmental
requirement of this transcription factor, but also an essential role
for podocyte maintenance. More recently, a novel missense muta-
tion (R246Q) within the LMX1B gene was  identiﬁed to be associated
with a nail-patella-like renal disease (NPLRD). This pathological
entity is characterized by nephropathy without the typical nail and
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espective mutation still resulted in residual transcriptional activ-
ty, the authors suggested that LMX1B haploinsufﬁciency might be
ausative for the nephropathy-only phenotype in NPLRD patients
142]. In analogy to this study, the segregation of the same muta-
ion within the LMX1B gene in pedigrees of patients with features of
utosomal dominant focal segmental glomerulosclerosis has been
escribed [143].
.3. MAFB, TCF21 and various more transcription factors related
o glomerular speciﬁcation
Next to WT1  and LMX1B, Pod1 and also Mafb appear to play deci-
ive roles in podocyte development, as knockout studies for both
f these transcription factors showed severe maturation defects in
odocytes [144,145].
Pod1 (also known as Capsulin, Tcf21 or Epicardin) belongs to the
asic helix-loop-helix transcription factors and is present in cells of
esenchymal origin. Hereby, Pod1 is not exclusively expressed in
he kidney, but also in the lung, gut and heart [144]. In the develop-
ng kidney, POD1 is detected as early as in the S-shaped glomerular
odies and in particular also in the presumptive podocyte popula-
ion [144]. Pod1 KO mice show perinatal lethality due to defects in
ung and cardiac development [146]. With regards to the expression
f Pod1 in the metanephric mesenchyme, also defects in tubu-
ar epithelial differentiation and branching morphogenesis were
bserved. Glomeruli of Pod1 KO mice display a severe glomerular
aturation defect [144]. Using microarray analysis of embryonic
lomeruli from Pod1 KO mice allowed for the identiﬁcation of puta-
ive target genes such as Nphs2 and Rhophilin [147]. More recently,
 conditional Pod1 allele was utilized to delete Pod1 at the capil-
ary loop stage (using Nphs2Cre) or in podocyte precursors (using
nt4Cre). While deletion with the Nphs2Cre line resulted in retar-
ation of glomerular maturation and ﬁnally in the development
f focal segmental glomerulosclerosis, knockout of Pod1 using the
nt4Cre line induced a dramatic differentiation defect in podocytes
ccompanied by perinatal renal failure [148]. Gene array analy-
is of respective Pod1*Nphs2Cre mice demonstrated that a series
f pro-angiogenic secreted factors like VEGF-A, DLL4 and solu-
le FLT1 exhibited decreased expression in Pod1-deﬁcient animals.
ltogether these observations indicate an essential role for Pod1 in
nitial podocyte differentiation and maintenance.
MAFB is reported to be expressed in capillary-loop stage
lomeruli [145]. MAFB (also termed Kreisler) belongs to the fam-
ly of basic domain leucine zipper (bZip) transcription factors and
s involved in the patterning and segmentation of the hindbrain
egion [149]. In respect to the glomerulus, Mafb KO mice show a
uite similar phenotype as Pod1 KO animals, with a severe matu-
ational defect of developing glomeruli and podocytes [145,150].
nterestingly, a more recent study could demonstrate that Mafb
verexpression in podocytes ameliorates the course of diabetic
ephropathy by stabilization of slit diaphragm molecules like
ephrin, upregulation of antioxidative enzymes and modulation
f Notch signaling pathways [151]. These ﬁndings might indicate
hat Mafb-controlled transcriptional networks involve adaptive
echanisms required in disease states. Moreover, a MAFB-GFP
ouse line allowed for FACS-based isolation of podocytes at differ-
nt developmental stages and enabled to generate comprehensive
ranscriptome databases to analyze changes in gene expression
uring glomerular maturation [152].
.4. Recent advances in the identiﬁcation of new podocyte
ranscription factorsEarly B-cell factor 1 (Ebf1) belongs to the helix-loop-helix tran-
cription factor family and was originally described as an important
actor in B-cell maturation [153]. Surprisingly, a very recent studypmental Biology 36 (2014) 39–49 45
demonstrated that Ebf1 is also expressed in developing renal cor-
tices and glomeruli. Employing an Ebf1 null mouse model, it was
demonstrated that lack of EBF1 results in pathological vasculariza-
tion as well as podocyte dysfunction reﬂected by podocyte foot
process effacement. EBF1 might regulate VEGF-A expression in
podocytes, as VEGF levels were signiﬁcantly decreased in knockout
animals [154].
Odd-skipped related 1 (Osr1) is a zinc ﬁnger transcription factor
with an established role in early kidney development: Osr1 is one
of the early expressed intermediate mesoderm genes contribut-
ing to the patterning and speciﬁcation of the MM.  Osr1 knockout
mice display a lack of the MM while the nephric duct is still
formed [155]. Interestingly, a very recent study placed Osr1 in the
context of podocyte differentiation in the zebraﬁsh pronephros,
demonstrating that Osr1 acts downstream of Wt1a regulating the
expression of podocyte slit diaphragm genes Nphs1 and Podocin
[156]. While not conﬁrmed in the mouse, the study on osr1 func-
tion in zebraﬁsh provides a novel putative transcriptional network
involving Wt1→Osr1 and Lhx1 (Lim1 – a homeodomain contain-
ing transcription factor) in modulating the expression of essential
podocyte genes. Previously it was demonstrated that LHX1 deﬁ-
cient cells cannot differentiate into podocytes [157].
Another set of transcription factors involved in podocyte spec-
iﬁcation are the forkhead box containing proteins. By employing
a genetically encoded reporter based cell enrichment protocol, a
genetic ﬁngerprint of podocytes was  generated [158]. Hereby, Foxc2
was identiﬁed to be highly enriched in the podocyte population
and the relevance of this respective transcription factor was  fur-
thermore underlined by analyzing Foxc2 knockout mice. The highly
conserved role of Fox transcription factors for podocyte differ-
entiation was also recently demonstrated by studies in zebraﬁsh
and Xenopus [159,160]. Several podocyte speciﬁc target genes
appear to be regulated by Foxc2 [158]. A very recent study could
demonstrate that Lmx1b and FoxC combinatorially modulate the
expression of Podocin and other podocyte genes via binding to a
podocyte-speciﬁc enhancer carrying a FLAT-E and forkhead DNA
binding motif [161].
Sox or Sry-high mobility group transcription factors represent
a large family with almost 20 individual factors in humans and
are involved in a variety of important developmental processes
like testis speciﬁcation, eye development, neurogenesis and many
more [162]. The whole SoxC subfamily, including SOX4, SOX11
and SOX12 are expressed in embryonic mouse kidney tissue [163].
Deletion of Sox4 in the metanephric mesenchyme resulted in a
severe glomerular maturation defect with reduced numbers of WT1
positive podocytes and decreased expression of Nphs1 [164].
5. The story of Notch and podocyte development
Notch signaling represents a highly conserved cell–cell commu-
nication platform in all metazoans and is known to be involved
in determination of individual cell identities [165]. There are two
transmembrane receptors (Notch-1 and Notch-2) and 2 different
ligands have been identiﬁed (Delta-like 1,3,4 and Jagged 1,2). The
importance of Notch signaling for renal function is underlined by
the autosomal-dominant Alagille syndrome, characterized by mul-
tisystemic organ involvement, including hepatic bile duct paucity
and concomitant cholestasis, as well as various cardiac, skeletal,
eye and renal abnormalities. Alagille syndrome is caused by muta-
tions in either the Notch2 receptor or the Jagged 1 ligand. The
renal phenotype ranges from renal tubular acidosis to kidney hypo-
/dysplasia [166].
First studies focusing on the role of Notch signaling in kidney
development were performed using metanephric kidney cul-
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N-S-phenyl-glycine-t-butyl ester). The -secretase complex is
ssentially involved in the Notch signaling cascade, as the com-
lex upon ligand binding mediates the cleavage of the extracellular
omain of the respective Notch receptor and allows for nuclear
ranslocation of the intracellular domain and subsequent expres-
ional regulation of Notch target genes [165]. The treatment of
idney culture explants with the -secretase inhibitor resulted
n normal mesenchymal condensation, but dysregulated proximal
ubule and podocyte differentiation [167]. In line with these obser-
ations, also the in vivo genetic inactivation of -secretase complex
omponents (Presenilin 1 and 2 – all involved in the activation
rocess of Notch receptor signaling) led to severe nephrogenesis
efects in respective KO mice as no comma- or S-shaped bodies
ere detectable [168]. A series of previous studies demonstrated
hat primarily the Notch-2 receptor appears to be involved in
he early fate decision of podocytes in glomerular development
62,169]. This notion was recently challenged by a study genetically
nactivating the transcription factor Rbpjk, a downstream mediator
f Notch signaling, [170]. As Rbpjk conditional KO mice exhibited
evere renal hypoplasia but rather normal differentiated podocytes,
he authors concluded that canonical Notch signaling is required
or proximal tubule fate decision but not for the speciﬁcation of
odocytes. While the genetic syndrome of Alagille syndrome sup-
orts the initial observations of the unequivocal importance of the
otch-2 receptor, studies in mice provided mechanistic insights
nto the predominant role for Notch-2 during kidney development
171]. By employing mouse models with swapped intracellular
omains of the Notch receptor (N1 and N2), it was established that
he N2 extracellular domain increases the amount of Notch protein
t the cell surface which is cleaved more efﬁciently upon ligand
inding (N2 more than N1).
Another very recent study demonstrated that also mesangial
ell development relies on Notch signaling [89]. Deletion of Rbpjk in
he stromal compartment of the metanephric mesenchyme (Foxd1-
re) resulted in the formation of glomerular aneurysms and was
haracterized by an inability of presumptive mesangial precursors
o coalesce next to forming nephrons (and thereby discriminates
his phenotype from a pure migratory defect of this population).
. Conclusion
Kidneys represent the most complex multi-tissue, multi-cellular
nd multifunctional organ. From the ﬁrst descriptive studies of
idney development to milestones in the identiﬁcation of recipro-
al inductive signaling between ureteric bud and the metanephric
esenchyme, a complex network of pathways, transcription fac-
ors and soluble factors driving nephrogenesis has been emerged.
ith the advent of the epigenetic era another level of complexity
s now added [172,173]. Nevertheless, there are still unanswered
uestions regarding complex fate decisions of individual cell popu-
ations, reliable identiﬁcation of progenitor populations and the
mpact of these regulatory networks on renal maintenance and
cquired kidney diseases.
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